Ovixan (Mometasone Furoate)

Mometasone furoate, the active ingredient in Ovixan, is a glucocorticoid corticost presented as a strength/form for topical use. It treats inflammatory skin conditions such as eczema and psoriasis in adults and children.

GNH USA supplies Ovixan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ovixan is a glucocorticoid that modulates inflammatory pathways in the skin. - Atopic dermatitis: reduces redness, itching and swelling. - Psoriasis: helps to clear plaques and lessen scaling. - Contact dermatitis: alleviates irritation and inflammation.

Adverse reactions may occur with topical glucocorticoid therapy.

Common Side Effects: - Skin burning or stinging sensation. - Mild itching or dryness. - Erythema or mild irritation. - Folliculitis. - Telangiectasia with prolonged use.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Secondary bacterial, fungal or viral infection. - Hypersensitivity or allergic contact dermatitis. - Systemic cortisol suppression with extensive application. - Hypertrichosis. - Delayed wound healing.

When using Ovixan, follow these safety measures: - Avoid: Avoid the re‑​ un‑ un ​   un  un  - Use   t",